Infection of Nonhost Species Dendritic Cells In Vitro with an Attenuated Myxoma Virus Induces Gene Expression That Predicts Its Efficacy as a Vaccine Vector

Recombinant myxoma virus (MYXV) can be produced without a loss of infectivity, and its highly specific host range makes it an ideal vaccine vector candidate, although careful examination of its interaction with the immune system is necessary. Similar to rabbit bone marrow-derived dendritic cells (BM...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Top, S., Foulon, E., Pignolet, B., Deplanche, M., Caubet, C., Tasca, C., Bertagnoli, S., Meyer, G., Foucras, G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2011
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3233174/
https://ncbi.nlm.nih.gov/pubmed/21835800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00128-11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak